McKesson Says IRS Overreads Law Backing Pricing Rules
Pharmaceutical giant McKesson asked a Texas federal court to invalidate transfer pricing regulations that underpin the company's $10 million tax refund bid, arguing the U.S. government mistakenly thinks the underlying statute...To view the full article, register now.
Already a subscriber? Click here to view full article